SiBionics - Amplifying its CGM solution with Nordic's nRF54L15

SiBionics, a Chinese MedTech firm based in Shenzhen (Guangdong province), specializes in the R&D and commercialization of advanced active implantable medical devices and imaging AI. With R&D facilities in both China and Los Angeles, SiBionics operates across several medical-based verticals that focus on chronic disease diagnosis and management.

“We continuously innovate and iterate our products through implantable medical hardware technology and artificial intelligence algorithms, dedicated to driving global innovation and the popularization of continuous biomarker monitoring products,” explains Wayne Zhang, SiBionic’s Supply Chain Director. 

Among these is Continuous Glucose Monitoring (CGM) – non-stop, real-time tracking of a person’s blood sugar levels through wearable, implantable devices. While marketed primarily to people afflicted with diabetes, other groups have also shown interest in these devices. 

As Zhang explains, “Its main end-users are diabetic patients. However, with the increasing global health awareness, many non-diabetic groups are also accepting and using this product. This includes individuals with prediabetes, individuals with weight management needs, health-conscious individuals who monitor their blood glucose levels, and sports enthusiasts who optimize their metabolism and athletic performance through continuous glucose monitoring. These non-diabetic groups are gradually becoming part of the product's user base in the future years.”

Meet the world’s thinnest CGM device

Last year, SiBionics displayed its newest CGM solution - the SIBIONIS GS3 CGM system, consisting of a physically applied sensor and companion app. This device uses Nordic’s nRF54L15 System-on-Chip (SoC). 

At less than three millimeters thick, the GS3 is marketed as “the world’s thinnest” CGM, designed to be user-friendly, seamless, and for virtually anyone consistently monitoring glucose levels or afflicted with diabetes, including the elderly and children as young as three years old.  

Weighing less than two grams, the GS3 offers a 14-day wear-time with an 18-month shelf-life, as well as other notable features similar to its predecessor, the SIBIONIS GS1. This includes real-time glucose monitoring, Bluetooth connectivity, customizable alerts, water resistance, and actionable insights with medical-grade accuracy. Similarly, the GS1 also uses a Nordic component - the nRF52832 System-on-Chip.